MBRX icon

Moleculin Biotech
MBRX

Overview Fund Activity

19 hedge funds and large institutions have $1.53M invested in Moleculin Biotech in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 16 reducing their positions, and 8 closing their positions.

Holders
19
Holders Change
-5
Holders Change %
-20.83%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
16
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NFSG
1
Newbridge Financial Services Group
Florida
$4.05K
2
FIM
2
FWL Investment Management
Texas
$1.64K
3
NS
3
NBC Securities
Alabama
$1K

Top Sellers

1
AC
1
Armistice Capital
New York
$878K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$445K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$98.2K
4
BlackRock
4
BlackRock
New York
$73.7K
5
AWM
5
Atticus Wealth Management
Florida
$19.7K
Name Market Value Shares Shares
Change 		Shares
Change %
SPC
26
Sigma Planning Corp
Michigan
– – -12,000 Closed
HBW
27
Hazlett, Burt & Watson
West Virginia
– – -67 Closed
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
1
2